Realising the potential of precision medicine combined with personalised healthcare to improve the quality of life of people with allergies

• With precision medicine, we identify the mechanisms of allergic response to develop diagnostic tools and AIT treatments
• Our ambition is to deliver unparalleled personalised patient care through our extensive product portfolio, including all administration routes
• We continue to develop treatment solutions which can be adjusted to meet patient-specific profiles and needs

Changing the course of allergic disease through the largest portfolio of best-in class allergy AIT treatments

• We focus on delivering state-of-the-art quality products
• We deepen our knowledge of AIT and meet modern methodological standards for proving efficacy and safety

Nurturing scientific innovation and collaborating for long-term growth, creating value for our stakeholders

• We empower clinicians to make therapeutic decisions based on patients’ needs due to our broad AIT product portfolio
• We strive to offer patients unparalleled support
• We contribute to our society, where climate change and increasing pollution will result in half of people having allergies by 2050

Being a trusted partner in allergy management and making a lasting and positive contribution to society

• We unlock the potential of every colleague with lifelong learning and development
• We build on our pioneering heritage to embed innovative thinking into our ways of working, benefiting our people, patients and physicians
• We improve patient experience by collaborating with partners in technological innovation, molecular research and developments in allergy biomarkers and drug delivery methodologies